Science Explorer Interactive view Map
Company · Solna · Sweden

Affibody (Sweden)

affibody.seROR OpenAlex
Research works
58
▼ 32% vs 2013–17
Citations
3.8k
65.6 per fractional work
Top-10% rate
32.1%
record average 16.5%
Open access
50%
world 28%

Not ranked overall: Affibody (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.44× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 7.19× its world share, 1 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 6.28× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.69× its world share, 0 worksChemistryEngineering: 0.20× its world share, 0 worksEngineeringMaterials Science: 0.56× its world share, 0 worksMaterials ScienceMedicine: 3.72× its world share, 8 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.2×. Every wedge is a field page.

Who are the top researchers at Affibody (Sweden)?

Ranked on the composite score, Joachim Feldwisch lead among researchers whose main affiliation is Affibody (Sweden).

  1. 1 Joachim Feldwisch Sweden · #468,161 worldwide 100 citations · 20 works
All ranked researchers at Affibody (Sweden)

Which keywords describe research at Affibody (Sweden)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, PET Imaging, Targeted Therapy and Cancer Treatment.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 38 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 38 words, with their numbers
  1. Glycosylation21▲ 166×3 topics
  2. Monoclonal Antibodies17▲ 203×3 topics
  3. Therapeutic Antibodies17▲ 225×2 topics
  4. Antibody Engineering16▲ 269×1 topic
  5. Fc Receptors16▲ 269×1 topic
  6. PET Imaging9▲ 75×3 topics
  7. Targeted Therapy9▲ 72×4 topics
  8. Cancer Treatment8▲ 57×2 topics
  9. Radioimmunotherapy8▲ 363×1 topic
  10. Radiopharmaceuticals8▲ 363×1 topic
  11. Cancer7▲ 9.0×9 topics
  12. Chemotherapy6▲ 14×4 topics
  13. Monoclonal Antibody6▲ 139×2 topics
  14. Immune System6▲ 29×2 topics
  15. Breast Cancer5▲ 33×2 topics
  16. Glycans5▲ 115×1 topic
  17. Mucins5▲ 115×1 topic
  18. HER25▲ 302×1 topic
  19. Trastuzumab5▲ 214×1 topic
  20. Immunotherapy3▲ 9.0×8 topics
  21. Nanoparticles2▲ 3.1×6 topics
  22. Tumor Targeting2▲ 26×3 topics
  23. Biopharmaceuticals2▲ 42×3 topics
  24. Cancer Therapy2▲ 4.5×6 topics
  25. Tumor Regression2▲ 34×2 topics
  26. Gene Therapy2▲ 11×4 topics
  27. Recombinant Proteins2▲ 48×2 topics
  28. Immunogenicity1▲ 46×2 topics
  29. Arginine Deprivation1▲ 45×1 topic
  30. Bacterial Therapy1▲ 45×1 topic
  31. Lymphoma1▲ 14×2 topics
  32. Oxidative Stress1◆ 1.13×8 topics
  33. Protein Aggregation1▲ 27×1 topic
  34. Rituximab1▲ 13×2 topics
  35. Stability1▲ 11×1 topic
  36. Tumor Microenvironment1▲ 5.9×4 topics
  37. Imaging1▲ 5.2×2 topics
  38. Prognostic Factors1▲ 3.9×3 topics

Which research topics does Affibody (Sweden) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Radiopharmaceutical Chemistry and Applications, HER2/EGFR in Cancer Research and CAR-T cell therapy research.

Monoclonal and Polyclona…2Monoclonal and Polyclonal Antibodies Research: 2 fractional worksRadiopharmaceutical Chem…2Radiopharmaceutical Chemistry and Applications: 2 fractional worksHER2/EGFR in Cancer Rese…1HER2/EGFR in Cancer Research: 1 fractional worksCAR-T cell therapy research: 0 fractional worksMedical Imaging Techniques and Applications: 0 fractional worksGlycosylation and Glycoproteins Research: 0 fractional worksAdvanced biosensing and bioanalysis techniques: 0 fractional worksEscherichia coli research studies: 0 fractional worksCancer Research and Treatments: 0 fractional worksVirus-based gene therapy research: 0 fractional works
Radiology, Nuclear Medicine and ImagingOncologyMolecular BiologyEndocrinology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  2. 2 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 2 works
  3. 3 HER2/EGFR in Cancer Research Oncology 1 works
  4. 4 CAR-T cell therapy research Oncology 0 works
  5. 5 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
  6. 6 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  7. 7 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
  8. 8 Escherichia coli research studies Endocrinology 0 works
  9. 9 Cancer Research and Treatments Biotechnology 0 works
  10. 10 Virus-based gene therapy research Genetics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.4%not open49.6%

World: 28% of research is openly available.

with international co-authors33.1%domestic only66.9%

World: 19% is written across borders.

How has Affibody (Sweden)'s research output changed?

Output in 2018–2022 was 32% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Solna

All research institutions in Solna

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.